A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants

Large-scale populations in the world have been vaccinated with COVID-19 vaccines, however, breakthrough infections of SARS-CoV-2 are still growing rapidly due to the emergence of immune-evasive variants, especially Omicron. It is urgent to develop effective broad-spectrum vaccines to better control...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Han, Zi Bo, Liang, Yu, Zhang, Xue Feng, Jin, Yu Qin, Du, Li Fang, Shao, Shuai, Wang, Hui, Hou, Jun Wei, Xu, Ke, Lei, Wenwen, Lei, Ze Hua, Liu, Zhao Ming, Zhang, Jin, Hou, Ya Nan, Liu, Ning, Shen, Fu Jie, Wu, Jin Juan, Zheng, Xiang, Li, Xin Yu, Li, Xin, Huang, Wei Jin, Wu, Gui Zhen, Su, Ji Guo, Li, Qi Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Immunology and Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481243/
https://www.ncbi.nlm.nih.gov/pubmed/36004719
http://dx.doi.org/10.7554/eLife.78633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481243/
https://www.ncbi.nlm.nih.gov/pubmed/36004719
http://dx.doi.org/10.7554/eLife.78633

Ejemplares similares